4//SEC Filing
Kanes Stephen 4
Accession 0001562180-21-004338
CIK 0001597553other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 9:12 AM ET
Size
8.6 KB
Accession
0001562180-21-004338
Insider Transaction Report
Form 4
Kanes Stephen
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2021-06-15$58.80/sh−1,001$58,859→ 10,791 total - Award
Common Stock
2021-06-15+3,500→ 11,792 total
Footnotes (1)
- [F1]On March 25, 2020, the reporting person was granted Performance Stock Units (PSU) to acquire a total of 8,750 shares of common stock. The PSU vests upon the achievement of certain milestones, one of which was met on June 15, 2021, resulting in the vesting of the PSU as to 3,500 shares.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001612859
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 9:12 AM ET
- Size
- 8.6 KB